345 related articles for article (PubMed ID: 9165225)
1. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
[TBL] [Abstract][Full Text] [Related]
2. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS
Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973
[TBL] [Abstract][Full Text] [Related]
3. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
4. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S
Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206
[TBL] [Abstract][Full Text] [Related]
5. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.
Schloot NC; Willemen S; Duinkerken G; de Vries RR; Roep BO
J Autoimmun; 1998 Apr; 11(2):169-75. PubMed ID: 9650096
[TBL] [Abstract][Full Text] [Related]
6. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
7. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
8. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Belgian Diabetes Registry.
Abrams P; De Leeuw I; Vertommen J
Diabet Med; 1996 May; 13(5):415-9. PubMed ID: 8737022
[TBL] [Abstract][Full Text] [Related]
9. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
10. Insulin (auto)antibodies from human IDDM cross-react with retroviral antigen p73.
Hao W; Serreze DV; McCulloch DK; Neifing JL; Palmer JP
J Autoimmun; 1993 Dec; 6(6):787-98. PubMed ID: 8155257
[TBL] [Abstract][Full Text] [Related]
11. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
12. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
13. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
14. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
[TBL] [Abstract][Full Text] [Related]
15. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
[TBL] [Abstract][Full Text] [Related]
16. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
17. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
18. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
[TBL] [Abstract][Full Text] [Related]
19. [Insulin autoantibodies and islet cell antibodies in recently appearing diabetes mellitus type I. Association with age of manifestation and HLA phenotype].
Ziegler AG; Rabl W; Albert E; Standl E
Dtsch Med Wochenschr; 1991 Nov; 116(46):1737-41. PubMed ID: 1935660
[TBL] [Abstract][Full Text] [Related]
20. Occult CD45 T cell developmental defect in type 1 diabetes.
Faustman DL
Diabete Metab; 1993; 19(5):446-57. PubMed ID: 8056125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
